Back
Veru Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
15
VERU
Veru
Last Price:
0.59
Seasonality Move:
18.14%
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
763.49
Seasonality Move:
14.2%
Sell
15
Veru (VERU)
is a Sell
Is Veru a Buy, Sell or Hold?
- The current Veru [VERU] share price is $0.63. The Score for VERU is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- VERU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $782.51. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERU Stock Price Chart
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $782.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
VERU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 28.62 | Sell |
| Chaikin Money Flow: | 149560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.88) | Sell |
| Bollinger Bands (100): | (0.76 - 0.92) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -57.82 | Sell |
| Relative Strength Index (14 RSI): | 13.92 | Sell |
| Chaikin Money Flow: | -932953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (825.73 - 982.29) | Sell |
| Bollinger Bands (100): | (945.47 - 1158.45) | Sell |
VERU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Sell |
| 20-day SMA: | 0.77 | Sell |
| 50-day SMA: | 0.8 | Sell |
| 200-day SMA: | 0.88 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.79 | Sell |
| 200-day EMA: | 0.97 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 816.56 | Sell |
| 20-day SMA: | 877.34 | Sell |
| 50-day SMA: | 995.77 | Sell |
| 200-day SMA: | 1007.21 | Sell |
| 8-day EMA: | 819.7 | Sell |
| 20-day EMA: | 872.08 | Sell |
| 50-day EMA: | 958.25 | Sell |
| 200-day EMA: | 987.42 | Sell |
Veru Earnings Growth & VERU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.01 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.37 per share, and an increase next year of $0.59 per share.
Veru Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||